Literature DB >> 7437355

Psycho-maintenance in asthma: hospitalization rates and financial impact.

J F Dirks, J C Schraa, E L Brown, R A Kinsman.   

Abstract

Certain patient styles perpetuate chronic physical illness, defeat medical treatment, and increase the utilization of medical services. Two such extreme styles among asthmatic patients are indexed by the MMPI panic-fear scale, reflecting either (a) helpless dependency and anxiety, or (b) excessive inappropriate independence. The present findings indicate that both of these patient styles are related to excessively high hospitalization rates during the two 1-year periods after discharge from intensive treatment, even among patient groups having asthma of similar objective severity. The discussion centres upon the increased demand for medical services, and the need for early identification of patients whose personal styles contribute to the maintenance of illness.

Entities:  

Mesh:

Year:  1980        PMID: 7437355     DOI: 10.1111/j.2044-8341.1980.tb02562.x

Source DB:  PubMed          Journal:  Br J Med Psychol        ISSN: 0007-1129


  4 in total

1.  Health care use and quality of life among patients with asthma and panic disorder.

Authors:  Jonathan M Feldman; Paul M Lehrer; Soo Borson; Teal S Hallstrand; Mahmood I Siddique
Journal:  J Asthma       Date:  2005-04       Impact factor: 2.515

2.  Scottish Confidential Inquiry into Asthma Deaths (SCIAD), 1994-6.

Authors:  C E Bucknall; R Slack; C C Godley; T W Mackay; S C Wright
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

3.  The role of panic-fear in comorbid asthma and panic disorder.

Authors:  Jonathan M Feldman; Mahmood I Siddique; Nigel S Thompson; Paul M Lehrer
Journal:  J Anxiety Disord       Date:  2008-07-01

4.  Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis.

Authors:  Li Zhang; Xin Zhang; Jing Zheng; Lan Wang; Hong-Ping Zhang; Lei Wang; Gang Wang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.